Free Trial
LON:AKR

Akers Biosciences (AKR) Share Price, News & Analysis

Akers Biosciences logo

About Akers Biosciences Stock (LON:AKR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
57.50
57.50
52-Week Range
N/A
Volume
262 shs
Average Volume
818 shs
Market Capitalization
£21.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akers Biosciences and its competitors with MarketBeat's FREE daily newsletter.

AKR Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

AKR Stock Analysis - Frequently Asked Questions

Shares of AKR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akers Biosciences investors own include SandRidge Permian Trust (PER), Rite Aid (RAD), AT&T (T), BP (BP), Cross Timbers Royalty Trust (CRT), Solbright Group (SBRT) and Workhorse Group (WKHS).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Trading
Current Symbol
LON:AKR
CIK
N/A
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.44
Quick Ratio
2.83

Sales & Book Value

Annual Sales
£2.32 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.90
Book Value
GBX 65.50 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
37,640,000
Free Float
N/A
Market Cap
£21.64 million
Optionable
Not Optionable
Beta
N/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:AKR) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners